Diebold Nixdorf, Incorporated

NYSE:DBD Stock Report

Market Cap: US$1.6b

Diebold Nixdorf Valuation

Is DBD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DBD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DBD ($42.8) is trading below our estimate of fair value ($131.53)

Significantly Below Fair Value: DBD is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DBD?

Key metric: As DBD is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DBD. This is calculated by dividing DBD's market cap by their current revenue.
What is DBD's PS Ratio?
PS Ratio0.4x
SalesUS$3.80b
Market CapUS$1.58b

Price to Sales Ratio vs Peers

How does DBD's PS Ratio compare to its peers?

The above table shows the PS ratio for DBD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
XRX Xerox Holdings
0.2x-0.5%US$1.0b
CMPO CompoSecure
3.2x6.5%US$1.3b
CRSR Corsair Gaming
0.5x10.2%US$690.0m
KODK Eastman Kodak
0.4xn/aUS$422.9m
DBD Diebold Nixdorf
0.4x1.2%US$1.6b

Price-To-Sales vs Peers: DBD is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.1x).

Price to Sales Ratio vs Industry

How does DBD's PS Ratio compare vs other companies in the US Tech Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
XRX Xerox Holdings
0.2x-0.5%US$1.05b
SONM Sonim Technologies
0.3x42.4%US$15.41m
QMCO Quantum
0.05x-2.1%US$14.28m
BRQS.F Borqs Technologies
0.2xn/aUS$5.79m
DBD 0.4xIndustry Avg. 1.0xNo. of Companies7PS01.22.43.64.86+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: DBD is good value based on its Price-To-Sales Ratio (0.4x) compared to the US Tech industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is DBD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DBD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: DBD is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DBD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$42.80
US$57.50
+34.3%
13.0%US$65.00US$50.00n/a2
Nov ’25US$46.54
US$57.50
+23.5%
13.0%US$65.00US$50.00n/a2
Oct ’25US$43.32
US$57.50
+32.7%
13.0%US$65.00US$50.00n/a2
Sep ’25US$44.82
US$57.50
+28.3%
13.0%US$65.00US$50.00n/a2
Aug ’25US$41.42
US$52.50
+26.8%
4.8%US$55.00US$50.00n/a2
Jul ’25US$40.28
US$52.50
+30.3%
4.8%US$55.00US$50.00n/a2
Jun ’25US$43.75
US$52.50
+20.0%
4.8%US$55.00US$50.00n/a2
May ’25US$31.16
US$41.50
+33.2%
3.6%US$43.00US$40.00n/a2
Apr ’25US$34.23
US$41.50
+21.2%
3.6%US$43.00US$40.00n/a2
Mar ’25US$32.98
US$41.50
+25.8%
3.6%US$43.00US$40.00n/a2
Feb ’25US$31.14
US$27.00
-13.3%
7.4%US$29.00US$25.00n/a2
Jan ’25US$28.95
US$27.00
-6.7%
7.4%US$29.00US$25.00n/a2
Dec ’24US$25.04
US$27.00
+7.8%
7.4%US$29.00US$25.00n/a2
Nov ’24US$18.34
US$22.50
+22.7%
11.1%US$25.00US$20.00US$46.542
Oct ’24US$18.94
US$22.50
+18.8%
11.1%US$25.00US$20.00US$43.322
Sep ’24US$18.66
US$22.50
+20.6%
11.1%US$25.00US$20.00US$44.822

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Arrow Electronics

US$6.0b

Provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

ARW

US$114.13

7D

-0.3%

1Y

-4.9%

LG Display

₩4.9t

Engages in the manufacture and sale of thin-film transistor liquid crystal display (TFT-LCD) and organic light emitting diode (OLED) technology-based display panels.

LPL

₩3.46

7D

3.6%

1Y

-32.8%

Gauzy

US$139.7m

An integrated light and vision control company, develops, manufactures, and supplies liquid crystal controllers and films in Israel, the United States, Europe, France, Asia, and internationally.

GAUZ

US$7.63

7D

-5.9%

1Y

n/a